Cargando…
Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial
BACKGROUND: The dramatic increase in the prevalence of type 2 diabetes mellitus (T2DM) is a global major challenge to health. Circulating microRNAs have been suggested as promising biomarkers for different disorders such as diabetes. Imbalances in the gut microbiome have been revealed to contribute...
Autores principales: | Zeinali, Fahime, Aghaei Zarch, Seyed Mohsen, Vahidi Mehrjardi, Mohammad Yahya, Kalantar, Seyed Mehdi, Jahan-mihan, Alireza, Karimi-Nazari, Elham, Fallahzadeh, Hossein, Hosseinzadeh-Shamsi-Anar, Mahdieh, Rahmanian, Masoud, Fazeli, Mohammad Reza, Mozaffari-Khosravi, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158024/ https://www.ncbi.nlm.nih.gov/pubmed/32290852 http://dx.doi.org/10.1186/s13063-020-04236-y |
Ejemplares similares
-
Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study
por: Zeinali, Fahime, et al.
Publicado: (2021) -
MicroRNA-122 in human cancers: from mechanistic to clinical perspectives
por: Faramin Lashkarian, Mahboobeh, et al.
Publicado: (2023) -
Circulating plasma microRNA-126, microRNA-145, and microRNA-155 and their association with atherosclerotic plaque characteristics
por: Knoka, Evija, et al.
Publicado: (2020) -
MicroRNA-214 and MicroRNA-126 Are Potential Biomarkers for Malignant Endothelial Proliferative Diseases
por: Heishima, Kazuki, et al.
Publicado: (2015) -
Trimetazidine Increases Plasma MicroRNA-24 and MicroRNA-126 Levels and Improves Dyslipidemia, Inflammation and Hypotension in Diabetic Rats
por: Ramezani-Aliakbari, Fatemeh, et al.
Publicado: (2020)